In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection

Despite the development of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection remains a major cause for liver disease and cancer worldwide. Entry inhibitors block virus host cell entry and, therefore, prevent establishment of chronic infection and liver disease. Due to their unique m...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antiviral Res
Hoofdauteurs: Mailly, Laurent, Wrensch, Florian, Heydmann, Laura, Fauvelle, Catherine, Brignon, Nicolas, Zeisel, Mirjam B., Pessaux, Patrick, Keck, Zhen-yong, Schuster, Catherine, Fuerst, Thomas R., Foung, Steven K.H., Baumert, Thomas F.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463510/
https://ncbi.nlm.nih.gov/pubmed/30599173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.12.018
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items